TISSUE
CELL
PATHOLOGY
Antibody validation
Dictionary
RENAL CANCER - Survival analysis
Best separation
Median separation
Expression cutoff
5-year survival high
5-year survival low
Log-rank P value
Interactive survival scatter plot (individual patient data)
High (n=194) Low (n=683) Alive (n=651) Dead (n=226) Female (n=286) Male (n=591) Stage: i (n=452) ii (n=103) iii (n=187) iv (n=103) n/a (n=32)
TCGA RNA samples
Average FPKM
Number of samples
Samples
Sample
Description
FPKM
High (n=417) Low (n=111) Alive (n=355) Dead (n=173) Female (n=184) Male (n=344) Stage: i (n=263) ii (n=57) iii (n=123) iv (n=82) n/a (n=3)
High (n=57) Low (n=228) Alive (n=241) Dead (n=44) Female (n=76) Male (n=209) Stage: i (n=170) ii (n=21) iii (n=50) iv (n=15) n/a (n=29)
High (n=17) Low (n=47) Alive (n=55) Dead (n=9) Female (n=26) Male (n=38) Stage: i (n=19) ii (n=25) iii (n=14) iv (n=6)
RENAL CANCER - Protein expression
Antibody HPA031707
Antibody HPA031708
Antibody HPA032045
Antibody CAB017840
Click images for details